![2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-N-[(2Z)-5-[3-(trifluoromethyl)benzyl]-1,3-thiazol-2(3H)-ylidene]acetamide in PDB entry 4uvd, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/4uvd_entity_4_side_image-200x200.png "Homo tetrameric assembly 1 of PDB entry <span class='highlight'>4uvd</span> contains 4 copies of <span class='highlight'>2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-N-[(2Z)-5-[3-(trifluoromethyl)benzyl]-1,3-thiazol-2(3H)-ylidene]acetamide</span>. Side view.")
![2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-N-[(2Z)-5-[3-(trifluoromethyl)benzyl]-1,3-thiazol-2(3H)-ylidene]acetamide in PDB entry 4uvd, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/4uvd_entity_4_top_image-200x200.png "Homo tetrameric assembly 1 of PDB entry <span class='highlight'>4uvd</span> contains 4 copies of <span class='highlight'>2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-N-[(2Z)-5-[3-(trifluoromethyl)benzyl]-1,3-thiazol-2(3H)-ylidene]acetamide</span>. Top view.")
Environment details NEW
HRW 1272 bound to chain A_3
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.